University Hospital of Umeå
Umeå, Sweden
Location status: Recruiting
NCT Number: NCT02960737
The aim of this study is to investigate the effect of a specific rehabilitation program with an oral device used in stroke patients with persistent oral-and pharyngeal dysphagia.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Umeå, Sweden
Location status: Recruiting
This study aims to investigate the effect of oral neuromuscular training in stroke patients with persistent oral- and pharyngeal dysphagia 12 (±3) weeks after stroke onset.
Interventional study with PROBE-design (prospective randomized open-label blinded evaluator). Consecutive patients with first-ever stroke without previously known dysphagia with persistent dysphagia (DOSS<6) at 3 months (12±3 weeks) post-stroke onset. Patients are eligible to participate if they are admitted to one of the following seven hospitals/centers in Sweden: Umeå University Hospital, Danderyds Hospital, Södersjukhuset, Skaraborg Hospital (Skövde), Helsingborg Hospital, Halland Hospital, Kungälv Hospital, Kalix Hospital, Skellefteå Hospital, and Ellenbogen in Malmö. Further centers will be recruited. Exclusion criteria: Unable/unwilling to give informed consent or to cooperate.
Randomization will be made web-based 1:1 by use of the developed REDCap system with stratification for center and aspiration (yes/no).
In total, 336 stroke patients (168 intervention group; 168 control group) with persistent dysphagia 12(±3) weeks after stroke onset will be included in the present study. The intervention group will be offered to undergo oral neuromuscular training alongside routine care with compensatory training for 3 months. The control group will only be offered routine care with compensatory training for 3 months.
The participants' status regarding swallowing function, nutritional status, quality of life related to swallowing, pneumonia, functional status including lip force, and death will be assessed before and after the completed intervention period, and 6 months post-intervention.
The primary endpoint will be analyzed using an ordinal regression (proportional odds) model, adjusting for baseline DOSS as well as for the stratifying variables center and aspiration.
The investigators hypothesize that swallowing intervention with oral neuromuscular training is more effective than routine care rehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The oral device is used for 30 seconds, three times a day, before meals and implies new possibilities for training of the orofacial and pharyngeal muscles.
Time frame: At start compared with at end of treatment (after 3 months)
Change in swallowing function measured by the Dysphagia Outcome Severity Scale (DOSS) using Fiberoptic endoscopic evaluation of swallowing (FEES)
Time frame: At start and 6 months post-intervention
Change in swallowing function measured by the Dysphagia Outcome Severity Scale (DOSS) using Fiberoptic endoscopic evaluation of swallowing (FEES)
Time frame: At start, at end of treatment (after 3 months) and 6 months post-intervention
Change in lip-force measured in newtons (N) with the Lip Force Meter LF100.
Time frame: At start, at end of treatment (after 3 months) and 6 months post-intervention
Change in quality of life related to swallowing measured by the SWAL-QOL questionnaire.
Time frame: At start, at end of treatment (after 3 months) and 6 months post-intervention
Change in nutritional status measured with the Mini Nutritional Assessment (MNA).
Time frame: At start, at end of treatment (after 3 months) and 12-18 months post-intervention
Change in activity of daily living (ADL) measured by Barthels Index (BI).
Time frame: At start, at end of treatment (after 3 months) and 6 months post-intervention
Change in global disability measured with modified Rankin Scale (mRS)
Time frame: At start, at end of treatment (after 3 months) and 6 months post-intervention
Change in rate of aspiration-pneumonia based on the modified criteria by Centers for Disease Control and Prevention (CDC) for stroke-associated pneumonia
Time frame: At start, at end of treatment (after 3 months) and 6 months post-intervention
Change in rate of death
Contact information is provided by the study sponsor or research team.
Patricia Hägglund, PhD/SLP
CONTACT
Per Wester, Professor
CONTACT
Umeå University
Other
Dysphagia Evaluation After Stroke - a Randomized Controlled Trial of Oral Neuromuscular Training on Swallowing Dysfunction (DESIRE)
Acronym: DESIRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06638944
Basal Ganglia Diseases, Brain Diseases
Champaign, Illinois, United States
View Trial DetailsNCT07620210
Brain Diseases, Cardiovascular Diseases
Tainan, Tainan City, Taiwan
View Trial DetailsNCT05591040
Brain Diseases, Cardiovascular Diseases
Venice-Lido, Italy
View Trial DetailsNCT07492719
Brain Diseases, Cardiovascular Diseases
Ankara, Turkey (Türkiye)
View Trial Details